Antitumor effect of soluble β-1,3-glucan from Agrobacterium sp. R259 KCTC 1019

Journal of Microbiology and Biotechnology

Volumn 17, Issue 9, 2007, Pages 1513-1520

  Shim, Jung Hyun ^a   Sung, Ki Joong ^a   Cho, Min Chul ^a   Choi, Won A ^b   Yang, Young ^c   Lim, Jong Seok ^c   Yoon, Do Young ^a  

^a Konkuk University   (South Korea)

^b DMJ Biotech Corp   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

1,3 Glucans; Adjuvant; Antitumor; Cytokine; Immune stimulating activity

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 1,3 GLUCAN; GAMMA INTERFERON; IMMUNOMODULATING AGENT; NITRIC OXIDE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; RHIZOBIUM; SPLEEN; THYMUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA-GLUCANS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED ICR; NEOPLASM METASTASIS; RHIZOBIUM; SOLUBILITY; WATER;

AGROBACTERIUM SP.; MUS;

EID: 35348897949     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bohn, J. and J. BeMiller. 1995. (1→3)-β-Glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydr. Polym. 28: 3-14.
2. Cheung, N., S. Modak, A. Vickers, and B. Knuckles. 2002. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunother. 51: 557-564.
3. Chihara, G. 1992. Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Dev. Biol. Stand. 77: 191-197.
4. Cho, Y., J. Cho, K. Lee, S. Park, and D. Yoon. 2000. Development of screening systems for drugs against human papillomavirus-associated cervical cancer: Based on E6-E6AP binding. Antiviral Res. 47: 199-206.
5. Colle, J., P. Falanga, M. Singer, B. Hevin, and G. Milon. 1997. Quantitation of messenger RNA by competitive RT-PCR: A simplified read out assay. J. Immunol. Methods 210: 175-184.
6. Di Luzio, N. 1985. Update on the immunomodulating activities of glucans. Springer Semin. Immunopathol. 8: 387-400.
7. Fujimoto, S. 1989. Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer. Nippon Geka Gakkai Zasshi 90: 1447-1450.
8. Ha, C. H., C. W. Yuri, H. D. Paik, S. W. Kim, C. W. Kang, H. J. Hwang, and H. I. Chang. 2006. Preparation and analysis of yeast cell wall mannoproteins, immune enhancing materials, from cell wall mutant Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 16: 247-255.
9. Ha, C. H., K. Lim, S. Jang, C. Yuri, H. Paik, S. Kim, C. Kang, and H. Chang. 2006. Immune-enhancing; alkali-soluble glucans produced by wild-type and mutant Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 16: 576-583.
10. Harada, T., N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno. 2002. IFN-gamma induction by SCG, 1,3-beta-D-glucan from Sparassis crispa, in DBA/2 mice in vitro. J. Interferon Cytokine Res. 22: 1227-1239.
11. Hong, K., K. Jang, J. Lee, S. Kim, M. Kim, I. Lee, S. Kim, Y. Lim, and S. Kang. 2005. Bacterial β-glucan exhibits potent hypoglycemic activity via decrease of serum lipids and adiposity, and increase of UCP mRNA expression. J. Microbiol. Biotechnol. 15: 823-830.
12. Kim, M., K. Ryu, W. Choi, Y. Rhee, and I. Lee. 2003. Enhanced production of (1,3)-β-D-glucan by a mutant strain of Agrobacterium sp. Biochem. Eng. J. 16: 163-168.
13. Kondo, Y., A. Kato, H. Hojo, S. Nozoe, M. Takeuchi, and K. Ochi. 1992. Cytokine-related immunopotentiating activities of paramylon, a beta-(1->3)-D-glucan from Euglena gracilis. J. Pharmacobiodyn. 15: 617-621.
14. 2-production as a sensitive and rapid assay for the quantitation of murine IFN-γ. J. Immunol. Methods 139: 107-114.
15. Mohagheghpour, N., M. Dawson, P. Hobbs, A. Judd, and R. Winant. 1995. Glucans as immunological adjuvants. Adv. Exp. Med. Biol. 383: 13-22.
16. Nathan, C., H. Murray, M. Wiebe, and B. Rubin. 1983. Identification of interferon-gamma as the the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689.
17. Nemoto, J., N. Ohno, K. Saito, Y. Adachi, and T. Yadomae. 1994. Analysis of cytokine mRNAs induced by the administration of a highly branched (1-->3)-beta-D-glucan, OL-2. Biol. Pharm. Bull. 17: 948-954.
18. Nicola, N. and D. Hilton. 1998. General classes and functions of four-helix bundle cytokines. Adv. Protein Chem. 52: 1-65.
19. Oka, M., S. Hazama, M. Suzuki, F. Wang, and K. Wadamori. 1996. In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. Int. J. Immunopharmacol. 18: 211-216.
20. Onozaki, K., K. Matsushima, and B. Aggarwal. 1985. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135: 3962-3968.
21. Onozaki, K., K. Matsushima, E. Kleinerman, T. Saito, and J. Oppenheim. 1985. Role of interleukin-1 in promoting human monocyte-mediated tumor cytotoxicity. J. Immunol. 135: 314-320.
22. Raveh, D., B. Kruskal, J. Farland, and R. Ezekowitz. 1998. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukocyte Biol. 64: 108-113.
23. Reizenstein, P. and G. Mathe. 1984. Immunomodulating agent. Immunol. Ser. 35: 347.
24. Rios-Hernandez, M., N. Dos-Santos, Silvia-Cardosa, J. Bello-Garciga, and M. Pedroso. 1994. Immunopharmacological studies of beta-1,3-glucan. Arch. Med. Res. 25: 175-180.
25. Seljeled, R., J. Bogwald, and A. Lundwall. 1981. Glycan stimulation of macrophages in vitro. Exp. Cell Res. 131: 121-129.
26. Sonn, C., H. Yoon, I. Seong, M. Chang, Y. Kim, H. Kang, S. Suh, and Y. Kim. 2006. MethA fibrosarcoma cells expressing membrane-bound forms of IL-2 enhance antitumor unmunity. J. Microbiol Biotechnol. 16: 1919-1927.
27. Suda, M., N. Ohno, Y. Adachi, and T. Yadomae. 1995. Modulation of the antitumor effect and tissue distribution of highly branched (1->3)-beta-D-glucan, SSG, by carrageenan. Biol. Pharm. Bull. 18: 772-775.
28. Taga, T. and T. Kishimoto. 1997. GP130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15: 797-819.
29. Taguchi, T., Y. Kaneko, and G. Chihara. 1988. Lentinan. Biotherapy 2: 509.
30. Tokunaka, K., N. Ohno, Y. Adachi, S. Tanaka, and H. Tamura. 2000. Immunopharmacological and immunotoxicological activities of a water-soluble (1->3)-beta-D-glucan, CSBG, from Candida spp. Int. J. Immunopharmacol. 22: 383-394.
31. Tsuzuki, A., T. Tateishi, N. Ohno, Y. Adachi, and T. Yadomae. 1999. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1->3)-beta-D-glucan preparation, sonifilan, in cyclophosphamide-induced leukopenic mice. Biosci. Biotechnol. Biochem. 63: 104-110.
32. Wasser, S. 2002. Medicinal mushrooms as a source of antitumor and immuno-modulating polysaccharides. Appl. Microbiol. Biotechnol. 60: 258-274.
33. Williams, D., H. Pretus, R. McNamee, E. Jones, H. Ensley, I. Browder, and N. Di Luzio. 1991. Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae. Immunopharmacology 22: 139-155.